Research Services for Life Sciences, Launched by Symyx

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on July 24, 2008

The scientific R&D integration partner to companies in the life sciences, chemicals, energy, electronics and consumer products industries - Symyx Technologies, Inc. - has recently launched its new client-directed and collaborative Research Services for Life Sciences.

These services allow clients to access Symyx's installed base of parallel experimentation and testing capabilities through packaged offerings for solubility studies, polymorph screening, salt selection, co-crystallization, API stability in liquid and solid formulations, excipient compatibility, organic synthesis and process optimization.

One of the first pharma company to sign an agreement with Symyx for Research Services for Life Sciences is Bristol-Myers Squibb.





Here are some ofthe benefits of Symyx's Research Services:

• Program flexibility: contract from a single experiment screen up to tens-of-thousands of experiments per year.


• Access to experiment capability to execute and analyze hundreds of experiments to deliver results in days not months.


• Greater experimental insight through development of more comprehensive data sets through automated parallel experimentation than can be achieved through traditional manual processes.


• Seamless replication of data and results to an existing customer-managed Symyx database.


• Dynamic access to data sets using Symyx Software which allows evaluation of full and raw data sets not static PDF reports.

Read the full Symyx press release. Check out Research Services for Life Sciences for more information.

[Thanks to Derek Brookmeyer for the hat tip!]